Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model.
Singh
Ajita V
AV
The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Palladino
Michael A
MA
Lloyd
George Kenneth
GK
Potts
Barbara C
BC
Chauhan
Dharminder
D
Anderson
Kenneth C
KC